Brigit Biofarmaka Teknologi Tbk. vs Surya Biru Murni Acetylene Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Surya Biru Murni Acetylene Tbk. trades at Rp111 (market cap 101.36B, 1.37M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Surya Biru Murni Acetylene Tbk. is more actively traded (1.37M versus 324K). Which is the better fit depends on your goals.
| OBAT | SBMA | |
|---|---|---|
Market Cap | 166.01B | 101.36B |
Volume | 324K | 1.37M |
Lot | 3.24K | 13.68K |
Turnover | 77.68M | 148.72M |
Average Price | 239.75 | 108.68 |
Value | 77.68M | 148.72M |
Indicative Equilibrium Price | 240 | 111 |
Indicative Equilibrium Volume | 1 | 1.25K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Surya Biru Murni Acetylene Tbk (the Company) was established in Balikpapan based on Notarial Deed No. 57 of Mohamad Rasjid Umar, S.H., dated October 25, 1980. The Company started its commercial operations in 1982.
Read more on SBMA →